SARS-CoV-2 Variant B.1.351(lsolate:South_Africa/KRISPK005325/2020) – CFHI
SARS-Related Coronavirus 2 Variant B.1.351 (Isolate: South_Africa/KRISP-K005325/2020) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. This virus was isolated from a nasopharyngeal swab from a 40-year-old human male on November 16, 2020 in the Ugu District, KwaZulu-Natal, South Africa. GISAID assigned lineage B.1.351 to SARS-CoV-2, Isolate South_Africa/KRISP-K005325/2020 using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome sequence can be found in (GISAID: EPI_ISL_678615). Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.
Heat inactivated viral culture fluids are sold as consumable testing materials. The suitability and performance characteristics should be determined by your laboratory for each intended usage. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
For BSL-2 or BSL-3 compliant labs only. CCL required / -20? C.
Material Safety Data Sheet.pdf
|BTN - HC|